A group of 53 biotech leaders is expressing support for mifepristone in a letter to the FDA, urging the agency not to impose new restrictions on its use as an abortion medication and slamming a ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs for millions of people.